<VariationArchive VariationID="2164" VariationName="NM_213599.3(ANO5):c.191dup (p.Asn64fs)" VariationType="Duplication" Accession="VCV000002164" Version="73" RecordType="classified" NumberOfSubmissions="36" NumberOfSubmitters="33" DateLastUpdated="2024-07-29" DateCreated="2014-07-23" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17203" VariationID="2164">
      <GeneList>
        <Gene Symbol="ANO5" FullName="anoctamin 5" GeneID="203859" HGNC_ID="HGNC:27337" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22192473" stop="22283357" display_start="22192473" display_stop="22283357" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22214721" stop="22304912" display_start="22214721" display_stop="22304912" Strand="+" />
          </Location>
          <OMIM>608662</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_213599.3(ANO5):c.191dup (p.Asn64fs)</Name>
      <CanonicalSPDI>NC_000011.10:22221100:AAAAAAA:AAAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22221100" stop="22221101" display_start="22221100" display_stop="22221101" variantLength="1" positionVCF="22221100" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22242646" stop="22242647" display_start="22242646" display_stop="22242647" variantLength="1" positionVCF="22242646" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>N63fs</ProteinChange>
      <ProteinChange>N64fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.22221107dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.22221107dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.22242653dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.22242653dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015844.1" sequenceAccession="NG_015844" sequenceVersion="1" change="g.32932dup">
            <Expression>NG_015844.1:g.32932dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142649.2" sequenceAccession="NM_001142649" sequenceVersion="2" change="c.188dup">
            <Expression>NM_001142649.2:c.188dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001136121.1" sequenceAccession="NP_001136121" sequenceVersion="1" change="p.Asn63fs">
            <Expression>NP_001136121.1:p.Asn63fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.191dup" MANESelect="true">
            <Expression>NM_213599.3:c.191dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_998764.1" sequenceAccession="NP_998764" sequenceVersion="1" change="p.Asn64fs">
            <Expression>NP_998764.1:p.Asn64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_868" sequenceAccession="LRG_868">
            <Expression>LRG_868:g.32932dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.2" sequenceAccession="NM_213599" sequenceVersion="2" change="c.191dupA">
            <Expression>NM_213599.2:c.191dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.191dupA" MANESelect="true">
            <Expression>NM_213599.3:c.191dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142649.1" sequenceAccession="NM_001142649" sequenceVersion="1" change="c.188dupA">
            <Expression>NM_001142649.1:c.188dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA115378" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
        <XRef Type="rs" ID="137854521" DB="dbSNP" />
        <XRef Type="Interpreted" ID="424764" DB="ClinVar" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2L" Accession="RCV000002248" Version="31">
        <ClassifiedConditionList TraitSetID="553">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="8">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND Miyoshi muscular dystrophy 3" Accession="RCV000002247" Version="11">
        <ClassifiedConditionList TraitSetID="554">
          <ClassifiedCondition DB="MedGen" ID="C2750076">Miyoshi muscular dystrophy 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-03-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND not provided" Accession="RCV000082844" Version="58">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-01" SubmissionCount="14">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND Myopathy" Accession="RCV000414931" Version="5">
        <ClassifiedConditionList TraitSetID="2640">
          <ClassifiedCondition DB="MedGen" ID="C0026848">Myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-10-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND multiple conditions" Accession="RCV000627781" Version="11">
        <ClassifiedConditionList TraitSetID="39863">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND ANO5-related disorder" Accession="RCV000778317" Version="10">
        <ClassifiedConditionList TraitSetID="33472">
          <ClassifiedCondition DB="MedGen" ID="CN239193">ANO5-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-06" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND multiple conditions" Accession="RCV000627021" Version="5">
        <ClassifiedConditionList TraitSetID="43268">
          <ClassifiedCondition DB="MedGen" ID="C0410264">Achilles tendon contracture</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0241005">Elevated circulating creatine kinase concentration</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4024921">Lower limb amyotrophy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1836296">Lower limb muscle weakness</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0022680">Polycystic kidney disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND Gnathodiaphyseal dysplasia" Accession="RCV001196017" Version="9">
        <ClassifiedConditionList TraitSetID="552">
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND Intellectual disability" Accession="RCV001251667" Version="5">
        <ClassifiedConditionList TraitSetID="17021">
          <ClassifiedCondition DB="MedGen" ID="C3714756">Intellectual disability</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-01-01" SubmissionCount="1">Likely benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND Autosomal recessive limb-girdle muscular dystrophy" Accession="RCV002307353" Version="5">
        <ClassifiedConditionList TraitSetID="12373">
          <ClassifiedCondition DB="MedGen" ID="C2931907">Autosomal recessive limb-girdle muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND multiple conditions" Accession="RCV002476911" Version="4">
        <ClassifiedConditionList TraitSetID="9870">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2750076">Miyoshi muscular dystrophy 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.191dup (p.Asn64fs) AND ANO5-related muscular dystrophy" Accession="RCV003332991" Version="1">
        <ClassifiedConditionList TraitSetID="87063">
          <ClassifiedCondition>ANO5-related muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-05" NumberOfSubmissions="36" NumberOfSubmitters="33" DateCreated="2014-07-23" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general" Abbrev="ACMG, 2015">
          <ID Source="PubMed">25741868</ID>
          <ID Source="pmc">4544753</ID>
          <ID Source="DOI">10.1038/gim.2015.30</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20096397</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21186264</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21739273</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21820307</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22194990</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22336395</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22402862</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22499103</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22742934</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22980763</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23041008</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23606453</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23607914</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24022920</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24232312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24843231</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25891276</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26886200</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27708273</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27911336</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28187523</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30919934</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9673985</ID>
        </Citation>
        <DescriptionHistory Dated="2023-07-15">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-07-03">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-02-03">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39863" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36390" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANO5-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ANO5-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANO5-Related Disorders</ElementValue>
              </Name>
              <XRef ID="CN239193" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="87063" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="68733" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">ANO5-related muscular dystrophy</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="552" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="553" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="554" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6803" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 3</ElementValue>
                <XRef ID="Miyoshi+muscular+dystrophy+3/8905" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013222" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Miyoshi myopathy 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD3</ElementValue>
                <XRef Type="MIM" ID="613319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17653" />
                <XRef ID="17653" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="399096" DB="Orphanet" />
              <XRef ID="C2750076" DB="MedGen" />
              <XRef ID="MONDO:0013222" DB="MONDO" />
              <XRef Type="MIM" ID="613319" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="17021" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="22261" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Intellectual functioning disability</ElementValue>
                <XRef ID="228156007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability</ElementValue>
                <XRef ID="HP:0001249" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0001071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">intellectual disabilities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Intellectual developmental disorder</ElementValue>
                <XRef ID="110359009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MR</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11963" />
                <XRef ID="11963" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Retired, AAN/CNS, 2011">
                <ID Source="PubMed">21956720</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">34211152</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">34131312</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2014">
                <ID Source="PubMed">25157020</ID>
              </Citation>
              <XRef ID="C3714756" DB="MedGen" />
              <XRef ID="D008607" DB="MeSH" />
              <XRef ID="MONDO:0001071" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001249" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000730" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001267" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001286" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002122" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002192" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002316" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002382" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002386" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002402" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002458" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002482" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002499" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002543" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003767" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006833" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007154" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007176" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007180" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9870" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
            <Trait ID="6803" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 3</ElementValue>
                <XRef ID="Miyoshi+muscular+dystrophy+3/8905" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013222" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Miyoshi myopathy 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD3</ElementValue>
                <XRef Type="MIM" ID="613319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17653" />
                <XRef ID="17653" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="399096" DB="Orphanet" />
              <XRef ID="C2750076" DB="MedGen" />
              <XRef ID="MONDO:0013222" DB="MONDO" />
              <XRef Type="MIM" ID="613319" DB="OMIM" />
            </Trait>
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="43268" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="26107" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Lower limb muscle weakness</ElementValue>
                <XRef ID="HP:0007340" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C1836296" DB="MedGen" />
              <XRef Type="primary" ID="HP:0007340" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002065" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002477" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0009047" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="1198" Type="Finding">
              <Name>
                <ElementValue Type="Alternate">HYPERCKEMIA, IDIOPATHIC</ElementValue>
                <XRef Type="MIM" ID="123320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Elevated serum creatine phosphokinase</ElementValue>
                <XRef ID="HP:0003236" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Elevated circulating creatine kinase concentration</ElementValue>
                <XRef ID="HP:0003236" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CAV3-Related Isolated HyperCKemia</ElementValue>
              </Name>
              <XRef ID="C0241005" DB="MedGen" />
              <XRef ID="MONDO:0007402" DB="MONDO" />
              <XRef Type="MIM" ID="123320" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003236" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002147" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002906" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003078" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003525" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003531" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008164" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="22597" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Achilles tendon contracture</ElementValue>
                <XRef ID="HP:0001771" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0410264" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001771" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004711" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005031" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006430" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="17137" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney dysplasia</ElementValue>
                <XRef ID="HP:0000113" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kidney, Polycystic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease</ElementValue>
                <XRef ID="MONDO:0020642" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS173900" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7419" />
                <XRef ID="7419" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0022680" DB="MedGen" />
              <XRef ID="D007690" DB="MeSH" />
              <XRef ID="MONDO:0020642" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS173900" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000113" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004716" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004739" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004740" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008645" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008673" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008699" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="26048" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Lower limb amyotrophy</ElementValue>
                <XRef ID="HP:0007210" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4024921" DB="MedGen" />
              <XRef Type="primary" ID="HP:0007210" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2640" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9536" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myopathy</ElementValue>
                <XRef ID="HP:0003198" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscle disorders</ElementValue>
              </Name>
              <XRef ID="C0026848" DB="MedGen" />
              <XRef ID="D009135" DB="MeSH" />
              <XRef ID="MONDO:0005336" DB="MONDO" />
              <XRef Type="primary" ID="HP:0003198" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003569" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003705" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003742" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003802" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12373" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0015152" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19825" />
                <XRef ID="19825" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="102015" DB="Orphanet" />
              <XRef ID="C2931907" DB="MedGen" />
              <XRef ID="MONDO:0015152" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS253600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="962409" SubmissionDate="2016-11-12" DateLastUpdated="2017-01-13" DateCreated="2017-01-13">
        <ClinVarSubmissionID localKey="CMGVARID00321|HPO:HP:0003198" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000492753" DateUpdated="2017-01-13" DateCreated="2017-01-13" Type="SCV" Version="1" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0003198" />
          </Trait>
        </TraitSet>
        <StudyDescription>Diagnostic exome sequencing variant classification from diagnostic exome sequencing programme</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>CMG_Slovenia_Submission_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1455816" SubmissionDate="2017-12-08" DateLastUpdated="2018-05-12" DateCreated="2018-05-12">
        <ClinVarSubmissionID localKey="CMGVARID00922|HPO:HP:0001771;HP:0003236;HP:0007210;HP:0007340;HP:0000113" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000747724" DateUpdated="2018-05-12" DateCreated="2018-05-12" Type="SCV" Version="1" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001771" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0003236" />
          </Trait>
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0007210" />
          </Trait>
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0007340" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0000113" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>CMG_Slovenia_Submission_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="22405" SubmissionDate="2018-09-25" DateLastUpdated="2018-09-28" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608662.0004_MIYOSHI MUSCULAR DYSTROPHY 3" title="ANO5, 1-BP DUP, 191A_MIYOSHI MUSCULAR DYSTROPHY 3" />
        <ClinVarAccession Accession="SCV000022405" DateUpdated="2018-09-28" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-03-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Bolduc et al. (2010) found homozygosity for a 1-bp duplication (191dupA) in exon 5 of the ANO5 gene in a Dutch family with Miyoshi muscular dystrophy-3 (MMD3; 613319) originally reported by Linssen et al. (1998) as family IV. The 191dupA mutation resulted in a frameshift and premature termination, consistent with a loss of function. It was absent in 210 French Canadian and 152 CEPH control chromosomes, but was identified in 1 of 100 UK and 2 of 210 Dutch control chromosomes.</Attribute>
              <Citation>
                <ID Source="PubMed">20096397</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9673985</ID>
              </Citation>
              <XRef DB="OMIM" ID="613319" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 63-year-old French Canadian woman with autosomal recessive limb-girdle muscular dystrophy type 2L (LGMDR12; 611307) and mild distal limb weakness, Bolduc et al. (2010) identified compound heterozygosity for 191dupA and a 692G-T transversion in exon 8 of the ANO5 gene, resulting in a gly231-to-val substitution (G231V; 608662.0005) in the intracellular N-terminal tail. The patient had late-onset asymmetric proximal upper limb and iliopsoas weakness and distal upper and lower limb weakness, as well as increased serum creatine kinase. Bolduc et al. (2010) noted that the phenotype overlapped between LGMD2L and Miyoshi myopathy.</Attribute>
              <Citation>
                <ID Source="PubMed">20096397</ID>
              </Citation>
              <XRef DB="OMIM" ID="611307" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Among 25 patients, mostly of Finnish descent, with variable muscle disorders due to recessive ANO5 mutations, Penttila et al. (2012) found that 191dupA was the second most common mutation, occurring in the heterozygous state with another ANO5 mutation in 10 patients. The phenotype was highly variable: female mutation carriers had a mild disorder with myalgia and/or calf hypertrophy and hyperCKemia, whereas men with the mutation showed distal lower limb weakness or proximal upper and lower limb muscle weakness. The findings indicated that this mutation can be associated with a variety of muscle phenotypes. Two Spanish brothers with LGMD2L were compound heterozygous for 191dupA and G231V.</Attribute>
              <Citation>
                <ID Source="PubMed">22402862</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <Name>ANO5, 1-BP DUP, 191A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 191A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608662.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MIYOSHI MUSCULAR DYSTROPHY 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1577839" SubmissionDate="2018-09-25" DateLastUpdated="2018-09-28" DateCreated="2018-09-28">
        <ClinVarSubmissionID localKey="608662.0004_MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12" title="ANO5, 1-BP DUP, 191A_MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12" />
        <ClinVarAccession Accession="SCV000809056" DateUpdated="2018-09-28" DateCreated="2018-09-28" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-03-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Bolduc et al. (2010) found homozygosity for a 1-bp duplication (191dupA) in exon 5 of the ANO5 gene in a Dutch family with Miyoshi muscular dystrophy-3 (MMD3; 613319) originally reported by Linssen et al. (1998) as family IV. The 191dupA mutation resulted in a frameshift and premature termination, consistent with a loss of function. It was absent in 210 French Canadian and 152 CEPH control chromosomes, but was identified in 1 of 100 UK and 2 of 210 Dutch control chromosomes.</Attribute>
              <Citation>
                <ID Source="PubMed">20096397</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9673985</ID>
              </Citation>
              <XRef DB="OMIM" ID="613319" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 63-year-old French Canadian woman with autosomal recessive limb-girdle muscular dystrophy type 2L (LGMDR12; 611307) and mild distal limb weakness, Bolduc et al. (2010) identified compound heterozygosity for 191dupA and a 692G-T transversion in exon 8 of the ANO5 gene, resulting in a gly231-to-val substitution (G231V; 608662.0005) in the intracellular N-terminal tail. The patient had late-onset asymmetric proximal upper limb and iliopsoas weakness and distal upper and lower limb weakness, as well as increased serum creatine kinase. Bolduc et al. (2010) noted that the phenotype overlapped between LGMD2L and Miyoshi myopathy.</Attribute>
              <Citation>
                <ID Source="PubMed">20096397</ID>
              </Citation>
              <XRef DB="OMIM" ID="611307" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Among 25 patients, mostly of Finnish descent, with variable muscle disorders due to recessive ANO5 mutations, Penttila et al. (2012) found that 191dupA was the second most common mutation, occurring in the heterozygous state with another ANO5 mutation in 10 patients. The phenotype was highly variable: female mutation carriers had a mild disorder with myalgia and/or calf hypertrophy and hyperCKemia, whereas men with the mutation showed distal lower limb weakness or proximal upper and lower limb muscle weakness. The findings indicated that this mutation can be associated with a variety of muscle phenotypes. Two Spanish brothers with LGMD2L were compound heterozygous for 191dupA and G231V.</Attribute>
              <Citation>
                <ID Source="PubMed">22402862</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <Name>ANO5, 1-BP DUP, 191A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 191A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608662.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1727198" SubmissionDate="2018-10-08" DateLastUpdated="2019-02-04" DateCreated="2019-02-04">
        <ClinVarSubmissionID localKey="7_1" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000882597" DateUpdated="2019-02-04" DateCreated="2019-02-04" Type="SCV" Version="1" SubmitterName="NeuroMeGen, Hospital Clinico Santiago de Compostela" OrgID="505605" OrganizationCategory="clinic" OrgAbbreviation="NeuroMeGen" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191_192insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2838494</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1789569" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="610629" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000914503" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22742934</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23607914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22402862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21739273</ID>
          </Citation>
          <Comment>The ANO5 c.191dupA (p.Asn64LysfsTer15) variant results in a frameshift and is predicted to result in premature termination of the protein. Across a selection of the available literature, the p.Asn64LysfsTer15 variant has been identified in at least 78 individuals with limb-girdle muscular dystrophy including 36 homozygotes and 42 compound heterozygotes; in two individuals with hyperCKemia in a compound heterozygous state; two individuals with myopathy, one in a homozygous state and one in a compound heterozygous state; three siblings with Miyoshi myopathy in a homozygous state; and eight individuals in a heterozygous state (Bolduc et al. 2010; Hicks et al. 2011; Deschauer et al. 2011; PenttilÃ¤et al. 2012; Magri et al. 2012; Sarkozy et al, 2013; Van der Kooi et al. 2013). The p.Asn64LysfsTer15 variant is reported as being one of the most common ANO5 pathogenic variants found in Northern European populations (Hicks et al., 2011). The p.Asn64LysfsTer15 variant has been reported in three of at least 500 control subjects and is reported at a frequency of 0.002186 in the population of the Exome Sequencing Project. Based on the potential impact of frameshift variants and collective evidence from the literature, the p.Asn64LysfsTer15 variant is classified as pathogenic for ANO5-Related Disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANO5-Related Disorders</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN239193" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2858429" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:665263" />
        <ClinVarAccession Accession="SCV001448041" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal unknown</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX170590</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003198" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2694527" SubmissionDate="2020-11-24" DateLastUpdated="2020-07-04" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_213599.2:c.191dupA|OMIM:166260" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001366446" DateUpdated="2020-07-04" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM3,PM4,PP4,PP3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166260" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3530461" SubmissionDate="2021-08-19" DateLastUpdated="2021-08-21" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey=":Chr.11_22242646_22242646_C_CA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001797445" DateUpdated="2021-08-21" DateCreated="2021-08-21" Type="SCV" Version="1" SubmitterName="Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)" OrgID="506395" OrganizationCategory="laboratory" OrgAbbreviation="LDGA" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10223652</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3787520" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-26" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey=":Chr.11_22242646_22242646_C_CA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001927435" DateUpdated="2021-09-26" DateCreated="2021-09-26" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, University Medical Center Utrecht" OrgID="274978" OrganizationCategory="laboratory" OrgAbbreviation="GDL-UMCU" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10419633</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5043298" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_213599.3:c.191dup|OMIM:611307" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002581828" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="13" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="137854521" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS4_MOD, PM3, PP1</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5082142" SubmissionDate="2022-11-10" DateLastUpdated="2022-11-19" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="NM_213599.2:c.191dupA|MedGen:C2931907" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002600595" DateUpdated="2022-11-19" DateCreated="2022-11-19" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9673985</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28187523</ID>
          </Citation>
          <Comment>Variant summary: ANO5 c.191dupA (p.Asn64LysfsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic within ClinVar (e.g. c.304_308del [p.Lys102fs], c.835C&gt;T [p.Arg279Ter]). The variant allele was found at a frequency of 0.0011 in 249002 control chromosomes in the gnomAD database, including 2 homozygotes. This frequency is not significantly higher than expected for a pathogenic variant in ANO5 causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (0.0011 vs 0.0047), allowing no conclusion about variant significance. c.191dupA has been reported in the literature as a biallelic genotype in multiple individuals affected with Limb-Girdle Muscular Dystrophy, Miyoshi Muscular Dystrophy, and Symptomatic/Asymptomatic HyperCKemia among other muscular disorders (e.g. Bolduc_2010, Savarese_2015, Papadopoulos_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Twenty-one ClinVar submitters have assessed the variant since 2014: one classified the variant as likely benign, one as likely pathogenic, and nineteen as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931907" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12274151</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5451825" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_213599.3:c.191dup|OMIM:166260;611307;613319" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002801207" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166260" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613319" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5502702" SubmissionDate="2022-12-17" DateLastUpdated="2023-01-07" DateCreated="2023-01-07">
        <ClinVarSubmissionID localKey="NM_213599.3:c.191dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002818219" DateUpdated="2023-01-07" DateCreated="2023-01-07" Type="SCV" Version="1" SubmitterName="Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12445851</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7171251" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="11-22242646-C-CA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003841578" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23041008</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22402862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27911336</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26886200</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22980763</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.106%). This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 4 similarly affected unrelated individuals (PMID: 22402862, 22980763, 23041008, 23606453, 25891276, 26886200, 27911336). The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000002164 / PMID: 20096397 / 3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003236" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003326" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008981" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12919228</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3374805" SubmissionDate="2024-01-05" DateLastUpdated="2024-01-26" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="417213|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001714372" DateUpdated="2024-01-26" DateCreated="2021-06-15" Type="SCV" Version="2" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Comment>PP1, PP5, PM3, PS4, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="9" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_213599.2:exon 5</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Asn64Lysfs*15</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14137495</SubmissionName>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3962142" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="486b7279b160710783e6dd27911f02825b52cbc0f28c79c4866b92e6113c96fb|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002017103" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1238419" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="733959|MedGen:C1969785;C1833736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000645880" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30919934</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21739273</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23607914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21739273</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23607914</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn64Lysfs*15) in the ANO5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANO5 are known to be pathogenic (PMID: 21186264, 23606453, 25891276, 30919934). This variant is present in population databases (rs575136178, gnomAD 0.2%), including at least one homozygous and/or hemizygous individual. This premature translational stop signal has been observed in individuals with autosomal recessive limb-girdle muscular dystrophy 2L (LGMD2L) and ANO5-related conditions (PMID: 20096397, 21186264, 21739273, 23606453, 23607914, 25891276). It is commonly reported in individuals of Northern European ancestry (PMID: 20096397, 21186264, 21739273, 23607914). ClinVar contains an entry for this variant (Variation ID: 2164). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.22242646_22242647insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969785" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833736" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7685126" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="781544|ANO5-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004109121" DateUpdated="2024-03-16" DateCreated="2023-11-20" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ANO5 c.191dupA variant is predicted to result in a frameshift and premature protein termination (p.Asn64Lysfs*15). This variant in the homozygous or compound heterozygous state has been reported in patients with autosomal recessive proximal limb-girdle muscular dystrophy or Miyoshi-like myopathy (Bolduc et al. 2010. PubMed ID: 20096397; Hicks et al. 2011. PubMed ID: 21186264; Bouquet et al. 2012. PubMed ID: 22336395). This variant is reported in 0.21% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in ANO5 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANO5-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="300754" SubmissionDate="2011-03-30" DateLastUpdated="2014-07-23" DateCreated="2014-07-23">
        <ClinVarSubmissionID localKey="ANO5_00004" />
        <ClinVarAccession Accession="SCV000172417" DateUpdated="2014-07-23" DateCreated="2014-07-23" Type="SCV" Version="1" SubmitterName="ANO5 @LOVD" OrgID="504785" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>r.(?)</Name>
            <Name>p.(Asn64Lysfs*15)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608662.0004" Type="Allelic variant" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Johan_den_Dunnen_2011-03-18_20.06.42</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1360279" SubmissionDate="2017-07-01" DateLastUpdated="2018-03-17" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="11-22242646-C-CA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000693897" DateUpdated="2018-03-17" DateCreated="2018-03-17" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Comment>The c.191dupA pathogenic variant is previously described Founder mutation within the Northern European population (PMID: 21186264).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <TypePlatform>WES</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" variantLength="1" />
          </Location>
          <OtherNameList>
            <Name>p.Asn64LysfsTer15</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>Broad Institute Center for Mendelian Genomics (CMG)</StudyName>
        <SubmissionNameList>
          <SubmissionName>Broad Institute Center for Mendelian Genomics (CMG)</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="476442" SubmissionDate="2018-08-31" DateLastUpdated="2018-02-15" DateCreated="2015-10-19">
        <ClinVarSubmissionID localKey="1844690|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000255643" DateUpdated="2018-02-15" DateCreated="2015-10-19" Type="SCV" Version="4" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23607914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24232312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22499103</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22194990</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22336395</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22402862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21820307</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22980763</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23041008</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24022920</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27708273</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24843231</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="575136178" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4481681</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="419575" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-30" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="5926_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000231252" DateUpdated="2019-07-30" DateCreated="2015-06-28" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000231253" DateChanged="2019-08-06" Version="3">
            <Comment Type="MergeComment">SCV000231253 was merged into SCV000231252 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000114896" DateChanged="2018-02-14" Version="3" />
        </ReplacedList>
        <Classification DateLastEvaluated="2016-08-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20096397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Comment>The c.191dupA ANO5 variant is a common pathogenic variant in the northern European population.1,2 1. Hicks et al. Brain. 2011 Jan;134(Pt 1):171-82. 2. Sarkozy et al. Hum Mutat. 2013 Aug;34(8):1111-8. AKT 4-29-16</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="98" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="23" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="70" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="A" referenceAllele="-" start="22242653" stop="22242654" variantLength="2" />
            <GeneLocation>NM_213599.2:Ex5</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI101059" />
            <XRef DB="dbSNP" ID="137854521" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">23757202</ID>
        </Citation>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=ANO5</URL>
        </Citation>
        <Comment>The c.191dupA ANO5 variant is a common pathogenic variant in the northern European population.1,2 1. Hicks et al. Brain. 2011 Jan;134(Pt 1):171-82. 2. Sarkozy et al. Hum Mutat. 2013 Aug;34(8):1111-8. AKT 4-29-16</Comment>
        <SubmissionNameList>
          <SubmissionName>EGL001</SubmissionName>
          <SubmissionName>EGL002</SubmissionName>
          <SubmissionName>EGL003</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
          <SubmissionName>PILOT_TEST_03</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2817457" SubmissionDate="2020-05-05" DateLastUpdated="2020-08-15" DateCreated="2020-08-15">
        <ClinVarSubmissionID localKey="NM_213599.2:c.191dup|HPO:HP:0001249" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001427407" DateUpdated="2020-08-15" DateCreated="2020-08-15" Type="SCV" Version="1" SubmitterName="Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille" OrgID="505759" OrganizationCategory="laboratory" OrgAbbreviation="CHRUL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely benign</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001249" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7391912</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3442835" SubmissionDate="2021-04-26" DateLastUpdated="2021-07-18" DateCreated="2021-07-18">
        <ClinVarSubmissionID localKey="nvtapin_15081_16474_16933_1" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001749728" DateUpdated="2021-07-18" DateCreated="2021-07-18" Type="SCV" Version="1" SubmitterName="GenomeConnect - Invitae Patient Insights Network" OrgID="508034" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant reported in multiple Invitae PIN participants. Variant interpreted as Pathogenic and reported most recently on 10/28/2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">60</Age>
              <Age Type="maximum" age_unit="years">69</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic|Family Testing</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <NamePlatform>Single Gene Sequencing|Familial/Targeted Variant Analysis</NamePlatform>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2019-11-11" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">nvtapin_15081</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2019-12-02" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000545" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011805" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011804" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0009127" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011438" />
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <NamePlatform>Gene Panel Sequencing</NamePlatform>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2020-01-14" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">nvtapin_16474_2</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2020-09-21" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002960" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002577" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011804" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0410009" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000836" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0100022" />
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <NamePlatform>Gene Panel Sequencing</NamePlatform>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2020-10-28" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">nvtapin_16933_2</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2020-10-30" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000545" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011968" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002577" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0010674" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000739" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000716" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000733" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN239193" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9483450</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3784453" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-26" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey=":Chr.11_22242646_22242646_C_CA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001925201" DateUpdated="2021-09-26" DateCreated="2021-09-26" Type="SCV" Version="1" SubmitterName="Clinical Genetics, Academic Medical Center" OrgID="319965" OrganizationCategory="laboratory" OrgAbbreviation="KG-DNA AMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10399984</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3864036" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-08" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey=":Chr.11_22242646_22242646_C_CA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001974455" DateUpdated="2021-10-08" DateCreated="2021-10-08" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3926252" SubmissionDate="2021-11-04" DateLastUpdated="2021-11-06" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="21Ord26012|OMIM:611307" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002011774" DateUpdated="2021-11-06" DateCreated="2021-11-06" Type="SCV" Version="1" SubmitterName="Clinical Genetics Laboratory, University Hospital Schleswig-Holstein" OrgID="508136" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.191dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10612416</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4932453" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000011.10:g.22221100_22221101insA|OMIM:166260" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002518471" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.22221100_22221101insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166260" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5403638" SubmissionDate="2022-12-14" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="sa_pathology/molecular_genetics_wch9/vc16044" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002761826" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_1552</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001142649.1:c.188dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0012652" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_37</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2267892" SubmissionDate="2022-12-20" DateLastUpdated="2022-12-24" DateCreated="2020-02-03">
        <ClinVarSubmissionID localKey="48-20200121" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001149685" DateUpdated="2022-12-24" DateCreated="2020-02-03" Type="SCV" Version="2" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0003198" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002359" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0003701" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MRIHUMGEN_STATUS_20220809</SubmissionName>
          <SubmissionName>SUB6902622</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="642305" SubmissionDate="2022-04-13" DateLastUpdated="2023-03-04" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:224404" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329066" DateUpdated="2023-03-04" DateCreated="2016-12-06" Type="SCV" Version="8" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Observed in the heterozygous state without a second variant in multiple individuals from a cohort of patients with limb-girdle muscular dystrophy and/or Miyoshi muscular dystrophy type 3 and related disorders; however, patient-specific data was not provided (Savarese et al., 2015; Sarkozy et al., 2013); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26810512, 25864073, 27142102, 26911675, 27708273, 24022920, 24843231, 23530687, 24232312, 21739273, 23607914, 22336395, 20096397, 23041008, 21186264, 26886200, 26913919, 30564623, 29794579, 30919934, 31395899, 31862442, 32403337, 31980526, 32399949, 31127727, 25891276, 34313030, 33837115, 23606453, 34106991, 31589614, 29417091, 32367299, 33258288, 25214167, 32819793, 33726816, 32528171, 32925086)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:3527</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_100_20220413054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3923552" SubmissionDate="2023-07-12" DateLastUpdated="2023-07-16" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="Chr.11_22221100_22221100_C_CA|not provided" />
        <ClinVarAccession Accession="SCV002009730" DateUpdated="2023-07-16" DateCreated="2021-11-06" Type="SCV" Version="3" SubmitterName="Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden" OrgID="505632" OrganizationCategory="clinic" OrgAbbreviation="KGE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="11" alternateAllele="CA" referenceAllele="C" start="22221100" stop="22221100" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10612882</SubmissionName>
          <SubmissionName>SUB13603663</SubmissionName>
          <SubmissionName>SUB13676335</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7562702" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="17840|ANO5-related muscular dystrophy" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004041208" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.191dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANO5-related muscular dystrophy</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13858663</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4897056" SubmissionDate="2024-04-12" DateLastUpdated="2024-04-15" DateCreated="2022-04-28">
        <ClinVarSubmissionID localKey="rmh/unit_1/hg38_NM_213599_3_ANO5_c_191dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002503669" DateUpdated="2024-04-15" DateCreated="2022-04-28" Type="SCV" Version="2" SubmitterName="Molecular Genetics, Royal Melbourne Hospital" OrgID="508231" OrganizationCategory="laboratory" OrgAbbreviation="RMH" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27708273</ID>
          </Citation>
          <Comment>This sequence change in ANO5 is a frameshift variant predicted to cause a premature stop codon, p.(Asn64Lysfs*15), in biologically relevant exon 5/22 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism. The highest population minor allele frequency in the population database gnomAD v4.0 is 0.27% (3,169/1,176,516 alleles, 4 homozygotes) in the European (non-Finnish) population. The variant is recognised to be a Northern European founder mutation for ANO5-related muscle disease and has been detected in the homozygous and compound heterozygous state in multiple affected individuals (PMID: 21186264, 27708273, 25891276). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PM3_VeryStrong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_1552</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.191dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0015152" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_12</SubmissionName>
          <SubmissionName>submission_41</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2467237" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="100442|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001245645" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ANO5: PM3:Very Strong, PVS1, PM2:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="23" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CA" referenceAllele="C" start="22242646" stop="22242646" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2694527" TraitType="Disease" MappingType="XRef" MappingValue="166260" MappingRef="OMIM">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962409" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003198" MappingRef="HP">
        <MedGen CUI="C0026848" Name="Myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011804" MappingRef="HP">
        <MedGen CUI="C4023182" Name="Abnormal muscle physiology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="419575" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4932453" TraitType="Disease" MappingType="XRef" MappingValue="166260" MappingRef="OMIM">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3923552" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455816" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001771" MappingRef="HP">
        <MedGen CUI="C0410264" Name="Achilles tendon contracture" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171251" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003326" MappingRef="HP">
        <MedGen CUI="C0231528" Name="Myalgia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000836" MappingRef="HP">
        <MedGen CUI="C0020550" Name="Hyperthyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3864036" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2267892" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003701" MappingRef="HP">
        <MedGen CUI="C0221629" Name="Proximal muscle weakness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000545" MappingRef="HP">
        <MedGen CUI="C0027092" Name="Myopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1238419" TraitType="Disease" MappingType="XRef" MappingValue="C1833736" MappingRef="MedGen">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Disease" MappingType="XRef" MappingValue="CN239193" MappingRef="MedGen">
        <MedGen CUI="CN239193" Name="ANO5-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2858429" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011438" MappingRef="HP">
        <MedGen CUI="C4023357" Name="Maternal teratogenic exposure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5451825" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000739" MappingRef="HP">
        <MedGen CUI="C0003467" Name="Anxiety" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1360279" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1577839" TraitType="Disease" MappingType="Name" MappingValue="MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12" MappingRef="Alternate">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2267892" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002359" MappingRef="HP">
        <MedGen CUI="C0850703" Name="Frequent falls" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1238419" TraitType="Disease" MappingType="XRef" MappingValue="C1969785" MappingRef="MedGen">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455816" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000113" MappingRef="HP">
        <MedGen CUI="C0022680" Name="Polycystic kidney disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3530461" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171251" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455816" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003236" MappingRef="HP">
        <MedGen CUI="C0241005" Name="Elevated circulating creatine kinase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171251" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003236" MappingRef="HP">
        <MedGen CUI="C0241005" Name="Elevated circulating creatine kinase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0010674" MappingRef="HP">
        <MedGen CUI="C4023747" Name="Abnormal curvature of the vertebral column" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100022" MappingRef="HP">
        <MedGen CUI="C0026650" Name="Movement disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0009127" MappingRef="HP">
        <MedGen CUI="C4024582" Name="Abnormality of the musculature of the limbs" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2817457" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2858429" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003198" MappingRef="HP">
        <MedGen CUI="C0026848" Name="Myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="22405" TraitType="Disease" MappingType="Name" MappingValue="MIYOSHI MUSCULAR DYSTROPHY 3" MappingRef="Preferred">
        <MedGen CUI="C2750076" Name="Miyoshi muscular dystrophy 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3926252" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171251" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008981" MappingRef="HP">
        <MedGen CUI="C1843057" Name="Calf muscle hypertrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5451825" TraitType="Disease" MappingType="XRef" MappingValue="166260" MappingRef="OMIM">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="300754" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3787520" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467237" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455816" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007210" MappingRef="HP">
        <MedGen CUI="C4024921" Name="Lower limb amyotrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3374805" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011804" MappingRef="HP">
        <MedGen CUI="C4023182" Name="Abnormal muscle physiology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5082142" TraitType="Disease" MappingType="XRef" MappingValue="C2931907" MappingRef="MedGen">
        <MedGen CUI="C2931907" Name="Autosomal recessive limb-girdle muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000545" MappingRef="HP">
        <MedGen CUI="C0027092" Name="Myopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="642305" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4897056" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0015152" MappingRef="MONDO">
        <MedGen CUI="C2931907" Name="Autosomal recessive limb-girdle muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000733" MappingRef="HP">
        <MedGen CUI="C0038271" Name="Motor stereotypies" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002577" MappingRef="HP">
        <MedGen CUI="C4025699" Name="Abnormal stomach morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3962142" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1789569" TraitType="Disease" MappingType="Name" MappingValue="ANO5-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN239193" Name="ANO5-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5502702" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002577" MappingRef="HP">
        <MedGen CUI="C4025699" Name="Abnormal stomach morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2267892" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003198" MappingRef="HP">
        <MedGen CUI="C0026848" Name="Myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0410009" MappingRef="HP">
        <MedGen CUI="C4073188" Name="Abnormality of the somatic nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7562702" TraitType="Disease" MappingType="Name" MappingValue="ANO5-related muscular dystrophy" MappingRef="Preferred">
        <MedGen CUI="None" Name="ANO5-related muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5043298" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3784453" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5403638" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0012652" MappingRef="MONDO">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7685126" TraitType="Disease" MappingType="Name" MappingValue="ANO5-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239193" Name="ANO5-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="476442" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455816" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007340" MappingRef="HP">
        <MedGen CUI="C1836296" Name="Lower limb muscle weakness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000716" MappingRef="HP">
        <MedGen CUI="C0011581" Name="Depression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011805" MappingRef="HP">
        <MedGen CUI="C4023181" Name="Abnormal skeletal muscle morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011968" MappingRef="HP">
        <MedGen CUI="C0232466" Name="Feeding difficulties" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442835" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002960" MappingRef="HP">
        <MedGen CUI="C0004368" Name="Autoimmunity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5451825" TraitType="Disease" MappingType="XRef" MappingValue="613319" MappingRef="OMIM">
        <MedGen CUI="C2750076" Name="Miyoshi muscular dystrophy 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1727198" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2267892" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2020-11-19">SCV001366829</Accession>
        <Description>Updated the reporting strategy binding the interpretation to OMIM (instead of HPO)</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2020-11-19">SCV001369781</Accession>
        <Description>Updated the reporting strategy binding the interpretation to OMIM (instead of HPO)</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001526455</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2020-11-19">SCV001370099</Accession>
        <Description>Updated the reporting strategy binding the interpretation to OMIM (instead of HPO)</Description>
      </SCV>
      <SCV>
        <Accession Version="4" DateDeleted="2018-09-27">SCV000022406</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

